Transparency

As a science-driven biotech, we have always worked closely with a variety of stakeholders in the scientific and healthcare sector. These relationships and partnerships are invaluable to Galapagos. We are proud of our collaborative spirit and will remain transparent about our research and business practices to our stakeholders. We believe that transparency is vital to strengthen the basis for future collaboration.

Transfers of Value

Under the applicable legislation and self-regulation codes, we disclose payments made to Healthcare Professionals, Healthcare Organizations and Patient Organizations, such as fee for services, support for events, grants and donations.

We publish Transfers of Value (ToV) made to these stakeholders in our markets across Europe. You can consult the Transfers of Values made in the reporting section below. Where there is a local platform in place, we encourage its usage and link to it. Our Methodology Note describes our commitment, our processes and the definitions of the ToV categories.

Transparency reporting for the different markets

2022 Transactions, published in 2023

2022 Transactions, published in 2023

2022 Transactions, published in 2023

2021 Transactions, published in 2022

2020 Transactions, published in 2021

www.transparantieregister.nl

R&D transfers of values to Dutch HCPs/HCOs

  • 2022: 1,600,223 euro
  • 2021: 1,245,416 euro
  • 2020: 500,056 euro

2022 Transactions, published in 2023

2022 Transactions, published in 2023

For Patient Organisations, Public, Patients and Journalists

For HCP / HCO